An article published Online First and in an upcoming edition of The Lancet reports that recent research indicates that aciclovir, used to treat HSV2, could delay HIV-1 disease progression in patients…
An article published Online First and in an upcoming edition of The Lancet reports that recent research indicates that aciclovir, used to treat HSV2, could delay HIV-1 disease progression in patients…
A phase III efficacy trial organized by the U.S. Military HIV Research Program and the Thai Ministry of Public Health, involving 16,000 volunteers in Thailand has revealed that volunteers who received…
By examining blood samples donated by infected people in developing countries, US researchers have found two new powerful antibodies to HIV that open the door to a new and effective AIDS…
Recent Comments